September 10 - 12, 2020

Bellagio
Las Vegas, NV

Daniel E. Furst, MD

Daniel E. Furst is Professor of Medicine at the University of California(emeritus), Los Angeles (UCLA), Medical Center, David Geffen School of Medicine, Department of Medicine, Division of Rheumatology. He is also Adjunct professor at the university of Washington, Seattle Washington and Research Professor at the University of Florence, Florence, Italy. He has part time practices at the Arthritis Associates of Southern California and the Seattle Rheumatology Associates in Seattle Washington. Dr. Furst received his MD from Johns Hopkins University, where he also completed his internship and residency. He completed two fellowships, one in Rheumatology at UCLA Medical Center, and a second in clinical pharmacology at the University of California, San Francisco Medical Center.

After serving as Assistant Professor of Medicine/Rheumatology at the UCLA Medical Center and as Associate Professor of Internal Medicine/Rheumatology at the University of Iowa Carver College of Medicine, he became Clinical Professor in the Department of Medicine, Division of Rheumatology and Connective Tissue Research at the University of Medicine and Dentistry of New Jersey. He later served as Director of Clinical Research Programs and the Arthritis Clinical Research Unit at the Virginia Mason Medical Center in Seattle, WA.  He has served on a number of national committees, and was a fellow in the American College of Rheumatology and The American Society of Clinical Pharmacology and Therapeutics. He has also been a member of the Arthritis Advisory Committee for the US Food and Drug Administration. He has served on the editorial boards of Inpharma, Clinical Drug Investigation, Drugs, The Journal of Clinical Rheumatology, and The Journal of Rheumatology. Additionally, he is an editorial reviewer for professional publications including Arthritis & Rheumatism, The New England Journal of Medicine, Journal of Clinical Investigation, Pharmacotherapy, and the Annals of the Rheumatic Diseases. His research interests include the clinical pharmacology of anti-rheumatic drugs and biologics, and the pathophysiology and treatment of systemic sclerosis.

 

Follow Us

Jointly Provided By

In Association With